Literature DB >> 2175909

Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies.

S Brimijoin1, V A Lennon.   

Abstract

Systemic injection of monoclonal antibodies to neural acetylcholinesterase in adult rats caused a syndrome with permanent, complement-mediated destruction of presynaptic fibers in sympathetic ganglia and adrenal medulla. Ptosis, hypotension, bradycardia, and postural syncope ensued. In sympathetic ganglia, acetylcholinesterase activity disappeared from neuropil but not from nerve cell bodies. Choline acetyltransferase activity and ultrastructurally defined synapses were also lost. Electrical stimulation of presynaptic fibers to the superior cervical ganglion ceased to evoke end-organ responses. On the other hand, direct ganglionic stimulation remained effective, and the postganglionic adrenergic system appeared intact. Motor performance and the choline acetyltransferase content of skeletal muscle were preserved, as was parasympathetic (vagal) function. This model of selective cholinergic autoimmunity represents another tool for autonomic physiology and may be relevant to the pathogenesis of human dysautonomias.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175909      PMCID: PMC55226          DOI: 10.1073/pnas.87.24.9630

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

2.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

3.  Autoimmune response to acetylcholine receptor.

Authors:  J Patrick; J Lindstrom
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

4.  A new method of destroying adrenergic nerves in adult animals using guanethidine.

Authors:  G Burnstock; B Evans; B J Gannon; J W Heath; V James
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

5.  Effects of anesthesia and sleep on circulatory response to carotid sinus nerve stimulation.

Authors:  S F Vatner; D Franklin; E Braunwald
Journal:  Am J Physiol       Date:  1971-05

6.  A sensitive enzymatic assay for dopamine- -hydroxylase.

Authors:  P B Molinoff; R Weinshilboum; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

7.  Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy.

Authors:  R Levi-Montalcini; P U Angeletti
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

8.  Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.

Authors:  V A Lennon; M E Seybold; J M Lindstrom; C Cochrane; R Ulevitch
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

9.  Myasthenia gravis: passive transfer from man to mouse.

Authors:  K V Toyka; D B Brachman; A Pestronk; I Kao
Journal:  Science       Date:  1975-10-24       Impact factor: 47.728

10.  On the origin and fate of external acetylcholinesterase in peripheral nerve.

Authors:  S Brimijoin; K Skau; M J Wiermaa
Journal:  J Physiol       Date:  1978-12       Impact factor: 5.182

View more
  5 in total

1.  Effects of neonatal removal of superior cervical ganglion on serotonin and thyrotropin-releasing hormone immunoreactivity in the intermediolateral cell column of the rat spinal cord.

Authors:  P Poulat; L Marlier; F Pellas; N Rajaofetra; A Privat
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Angiotensin II type 1 receptors may not influence response of spinal autonomic neurons to axonal damage.

Authors:  Hui Tang; Jaroslav Pavel; Juan M Saavedra; Stephen Brimijoin
Journal:  Neurol Res       Date:  2008-05-21       Impact factor: 2.448

3.  Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.

Authors:  Vanda A Lennon; Leonid G Ermilov; Joseph H Szurszewski; Steven Vernino
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Antibodies to acetylcholinesterase cross-reacting with thyroglobulin in myasthenia gravis and Graves's disease.

Authors:  D G Mappouras; G Philippou; S Haralambous; S J Tzartos; A Balafas; A Souvatzoglou; P Lymberi
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

5.  Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies.

Authors:  William T Gunning; Heather Kvale; Paula M Kramer; Beverly L Karabin; Blair P Grubb
Journal:  J Am Heart Assoc       Date:  2019-09-09       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.